ASX Share rice
Fri 07 Aug 2020 - 11:26:am (Sydney)

UBI Share Price

UNIVERSAL BIOSENSORS INC.UBIHealth Care Equipment & Services

UBI Company Information

Name:

Universal Biosensors, Inc

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment

Address:

1 Corporate Avenue Rowville VIC Australia 3178

Phone:

61 3 9213 9000

Full Time Employees:

39

CFO & Company Sec.:

Mr. Salesh Balak

Chief Exec. Officer:

Mr. John Stewart Sharman

Director of Operations & Manufacturing Engineering:

Ms. Judy Andrews

Chief Research Scientist:

Dr. Ronald Chatelier BSc. (Hons.), Ph.D.

Company Overview:

Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, designs and develops electrochemical cells in Australia. The company focuses on the research, development, and manufacture of medical or testing devices. It uses electrochemical cell technology platform to develop point of use devices for various industries, including healthcare, food and drink, and agriculture. The company offers prothrombin time international normalized ratio coagulation test strips; and coagulation testing and calibration services, as well as distributes Siemens' Xprecia Stride Coagulation Analyzer. It also owns, operates, and manages a hemostasis laboratory. The company was founded in 2001 and is based in Rowville, Australia.

UBI Share Price Information

Shares Issued:

177.57M

Market Capitalisation:

$44.39M

Revenue (TTM):

$3.98M

Revenue Per Share (TTM):

$0.02

Earnings per Share:

$0.192

Profit Margin:

-1.4735

Operating Margin (TTM):

$-3.01

Return On Assets (TTM):

$-0.12

Return On Equity (TTM):

$-0.13

Quarterly Revenue Growth (YOY):

-0.741

Gross Profit(TTM):

$3.33M

Diluted Earnings Per Share (TTM):

$-0.04

UBI CashFlow Statement

CashFlow Date:

2019-12-31

Investments:

$-10,281,242

Change To Liabilities:

$-3,847,299

Total Cashflow From Investing Activities:

$-10,281,242

Net Income:

$-4,846,285

Total Cash From Operating Activities:

$33.24M

Depreciation:

$1.51M

Other Cashflow From Investing Activities:

$3.38K

Change To Inventory:

$35.24K

Change To Account Receivables:

$50.09M

Capital Expenditures:

$10.31M

UBI Income Statement

Income Date:

2019-12-31

Income Before Tax:

$-6,163,764

Net Income:

$-4,846,285

Gross Profit:

$3.33M

Operating Income:

$-7,597,126

Interest Expense:

$0

Income Tax Expense:

$-1,317,479

Total Revenue:

$6.90M

Total Operating Expenses:

$14.49M

Cost Of Revenue:

$3.57M

UBI Balance Sheet

Balance Sheet Date:

2019-12-31

Intangible Assets:

$15.93M

Total Liabilities:

$17.27M

Total Stockholder Equity:

$45.39M

Other Current Liabilities:

$5.07M

Total Assets:

$62.66M

Common Stock:

$17.76K

Other Current Assets:

$3.46M

Retained Earnings:

$-47,679,272

Other Liabilities:

$7.10M

Other Assets:

$4.91M

Cash:

$30.23M

Total Current Liabilities:

$10.16M

Property - Plant & Equipment:

$4.75M

Net Tangible Assets:

$29.47M

Total Current Assets:

$37.07M

Net Receivables:

$116.63K

Short-Term Investments:

$25.59M

Inventory:

$1.08M

Accounts Payable:

$615.38K

Non Currrent Assets (Other):

$4.91M

Short-Term Investments:

$25.59

Non Current Liabilities (Other):

$2.60M

Non Current Liabilities Total:

$7.10M

UBI Share Price History

UBI News

30 Apr, 2020
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
25 Nov, 2019
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...